These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16804393)

  • 21. Enzyme-Linked Immunosorbent Assay to Measure S100A12 in Fecal Samples of Children and Adults.
    Leach ST; Day AS
    Methods Mol Biol; 2019; 1929():755-761. PubMed ID: 30710309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Manolakis AC; Kapsoritakis AN; Georgoulias P; Tzavara C; Valotassiou V; Kapsoritaki A; Potamianos SP
    BMC Gastroenterol; 2010 Oct; 10():118. PubMed ID: 20946669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of fecal S100A12 as a novel non-invasive diagnostic biomarker for pediatric inflammatory bowel disease: a systematic review and meta-analysis.
    Witarto BS; Visuddho V; Witarto AP; Sampurna MTA; Irzaldy A
    J Pediatr (Rio J); 2023; 99(5):432-442. PubMed ID: 37094752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Fecal ASCA Measurement as a Biomarker of Crohn Disease in Pediatric Patients.
    Tang V; Valim C; Moman R; Richman A; Zhou J; Ramgopal V; Albert R; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):248-253. PubMed ID: 27111346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
    Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal inflammation and impact on growth in children with cystic fibrosis.
    Dhaliwal J; Leach S; Katz T; Nahidi L; Pang T; Lee JM; Strachan R; Day AS; Jaffe A; Ooi CY
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):521-6. PubMed ID: 25539196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.
    Kopylov U; Rosenfeld G; Bressler B; Seidman E
    Inflamm Bowel Dis; 2014 Apr; 20(4):742-56. PubMed ID: 24562174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal S100A12 concentration predicts a lack of response to treatment in dogs affected with chronic enteropathy.
    Heilmann RM; Volkmann M; Otoni CC; Grützner N; Kohn B; Jergens AE; Steiner JM
    Vet J; 2016 Sep; 215():96-100. PubMed ID: 27017054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal S100A12: identifying intestinal distress in very-low-birth-weight infants.
    Däbritz J; Foell D; Wirth S; Jenke A
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):204-10. PubMed ID: 23549327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal M2-PK in children with Crohn's disease: a preliminary report.
    Day AS; Judd T; Lemberg DA; Leach ST
    Dig Dis Sci; 2012 Aug; 57(8):2166-70. PubMed ID: 22736014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
    Chung-Faye G; Hayee B; Maestranzi S; Donaldson N; Forgacs I; Sherwood R
    Inflamm Bowel Dis; 2007 Nov; 13(11):1374-8. PubMed ID: 17577247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical intestinal inflammation in siblings of children with Crohn's disease.
    Pham M; Leach ST; Lemberg DA; Day AS
    Dig Dis Sci; 2010 Dec; 55(12):3502-7. PubMed ID: 20931283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal Calprotectin as an Activity Marker of Inflammatory Bowel Disease in Children.
    Krzesiek E
    Adv Clin Exp Med; 2015; 24(5):815-22. PubMed ID: 26768632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.